Moody’s: WA Rec Sales Could Fall Short of Projections

Initial recreational cannabis sales in Washington State could fall “well short” of expectations due to high tax rates, competition from medical marijuana and delays in the licensing process, according to an updated outlook by Moody’s Investors Service.

As a result, the state’s total tax and licensing revenues from retail marijuana will likely be far lower than the $51.2 million Washington officials originally forecast for 2015-2017, the credit ratings agency warned.

The firm does not anticipate that the shortfall will affect the creditworthiness of the state, however, as no marijuana-related tax revenues were included in the budget through fiscal year 2015.

Moody’s said an estimated effective tax rate of 44% on recreational marijuana will significantly impact demand. These high taxes have helped lift retail cannabis prices well above rates in the underground and medical marijuana markets.

, Moody’s: WA Rec Sales Could Fall Short of Projections“The tax structure in Washington State is likely to be a major deterrent for consumers who do not see the value in obtaining the product from a storefront as opposed to a medical dispensary,” Andrea Unsworth, an analyst with Moody’s, said in a press release.

The firm also pointed to the fact that a fewer number of stores than expected opened when retail sales began earlier this month. Inventory challenges have also dampened sales for the recreational market as a whole.

Latest Headlines

2 comments on “Moody’s: WA Rec Sales Could Fall Short of Projections
  1. linda warren on

    Moodys: That name sounds like a flashback to pre economic melt-down…Did they not rate other economic opportunities….AAA bonds and toxic securities…sold as better investments…PS the amount of weed was a joke…demand side economics….wins the day.

  2. dr. tony on

    medical cannabis represents 15% of the total market, according to the washington liquor board and their consultant, mark kleiman. so now it’s a competitive threat? no…it’s just they can’t get any stores open or growers approved or product tested or distributed and medical is the only operating legal source in washington.

Leave a Reply

Your email address will not be published. Required fields are marked *